SCHEMBL16332015

SCHEMBL16332015

COc1ccc(Nc2nccc3c2cc(-c2ccsc2)n3C)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FYN P06241 1/20 0.48
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ ABCG2 Q9UNQ0 7/20 0.43
▸ EGFR P00533 3/20 0.43
▸ CLK1 P49759 2/20 0.43
▸ LCK P06239 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ ABCB1 P08183 3/20 0.39
▸ TNF P01375 3/20 0.39
▸ POLB P06746 2/20 0.39
▸ HTT P42858 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ ABCC1 P33527 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16331822 0.91 FYN (0.47) FYNMEN1KMT2AABCG2EGFR
SCHEMBL16331804 0.88 NPC1 (0.50) FYNMEN1KMT2AEGFRLCK
SCHEMBL16332609 0.85 FYN (0.56) FYNMEN1KMT2AABCG2EGFR
SCHEMBL16331528 0.85 CYP2A6 (0.44) FYNMEN1KMT2ALMNATP53
SCHEMBL16332052 0.83 FYN (0.39) FYNMEN1KMT2AABCG2EGFR
SCHEMBL16332075 0.83 FYN (0.40) FYNLMNATP53
SCHEMBL16331729 0.82 MEN1 (0.47) FYNMEN1KMT2AALDH1A1MAPT
SCHEMBL16332062 0.82 ABCG2 (0.53) FYNMEN1KMT2AABCG2EGFR
SCHEMBL16373491 0.81 FYN (0.46) FYNKMT2AEGFRALDH1A1MAPT
SCHEMBL16373693 0.81 FYN (0.46) FYNEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9458463-B2 Method for treatment of diabetes by a small molecule inhibitor for GRK5 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2016-10-04 — — US claimed
EP-2818472-A1 Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine compounds as G-protein-coupled receptor kinase 5 (GRK5) modulators Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-12-31 — — EP claimed
WO-2014207260-A1 PYRROLO[3,2-C]PYRIDINE COMPOUNDS AS G-PROTEIN-COUPLED RECEPTOR KINASE 5 (GRK5) MODULATORS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-12-31 — — WO disclosed
EP-2818472-A1 Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine compounds as G-protein-coupled receptor kinase 5 (GRK5) modulators Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-12-31 — — EP disclosed
Send feedback